ADIL
ADIAL PHARMACEUTICALS, INC.
Key Financials
Net Income
$-7977171
↑ 39.6%
Operating Income
$-7799462
↑ 5.9%
Total Liabilities
$1.4M
↑ 43.1%
Total Assets
$6.7M
↑ 32.3%
EPS (Diluted)
$-11.93
↓ 338.6%
Cash & Equivalents
$5.9M
↑ 56.8%
Shareholders' Equity
$5.3M
↑ 29.7%
Operating Cash Flow
$-6492603.00
↑ 6.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| PRE 14A | 8/11/2026 | View on SEC |
| 8-K/A | 8/11/2026 | View on SEC |
| 4 | 7/16/2026 | View on SEC |
| 4 | 7/13/2026 | View on SEC |
| SCHEDULE 13G/A | 7/1/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| 3 | 6/29/2026 | View on SEC |
| SCHEDULE 13G | 6/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADIL |
| Company Name | ADIAL PHARMACEUTICALS, INC. |
| CIK | 1513525 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 434-422-9800 |